Propel Bio Management’s State Street SPDR Portfolio Short Term Corporate Bond ETF SPSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-45,695
Closed -$1.36M 36
2023
Q4
$1.36M Buy
+45,695
New +$1.34M 1.13% 23

Other funds holding SPSB

Propel Bio Management's SPSB Position: Q1 2024 in Review

Propel Bio Management sold out of State Street SPDR Portfolio Short Term Corporate Bond ETF (SPSB) in Q1 2024, closing a stake of 45,695 shares — an estimated $1.36M sold.

Propel Bio Management first reported a position in SPSB in Q4 2023 and held it in 1 quarter. The position peaked at $1.36M in Q4 2023. 520 funds tracked by Wall St. Rank hold SPSB as of Q1 2024.

  • Propel Bio Management reported no remaining State Street SPDR Portfolio Short Term Corporate Bond ETF position as of Q1 2024 after selling out during the quarter.
  • Propel Bio Management sold 45,695 State Street SPDR Portfolio Short Term Corporate Bond ETF shares in Q1 2024, an estimated $1.36M.
  • Propel Bio Management first reported a position in State Street SPDR Portfolio Short Term Corporate Bond ETF in Q4 2023 and held it in 1 quarter.
  • Propel Bio Management's State Street SPDR Portfolio Short Term Corporate Bond ETF position peaked at $1.36M in Q4 2023.
  • 520 funds tracked by Wall St. Rank held State Street SPDR Portfolio Short Term Corporate Bond ETF as of Q1 2024.

Based on Propel Bio Management's 13F filing for Q1 2024, filed 13 May 2024.